JPH10165775A - Production of permselective hollow yarn membrane - Google Patents

Production of permselective hollow yarn membrane

Info

Publication number
JPH10165775A
JPH10165775A JP32528196A JP32528196A JPH10165775A JP H10165775 A JPH10165775 A JP H10165775A JP 32528196 A JP32528196 A JP 32528196A JP 32528196 A JP32528196 A JP 32528196A JP H10165775 A JPH10165775 A JP H10165775A
Authority
JP
Japan
Prior art keywords
hollow fiber
fiber membrane
hollow yarn
spinning
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP32528196A
Other languages
Japanese (ja)
Other versions
JP3236233B2 (en
Inventor
Shingo Emi
慎悟 江見
Koji Soga
宏治 曽我
Shoji Mizutani
昭治 水谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18175068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH10165775(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP32528196A priority Critical patent/JP3236233B2/en
Priority to CA002202969A priority patent/CA2202969C/en
Priority to EP97302660A priority patent/EP0801973A1/en
Priority to US08/837,475 priority patent/US6013182A/en
Publication of JPH10165775A publication Critical patent/JPH10165775A/en
Application granted granted Critical
Publication of JP3236233B2 publication Critical patent/JP3236233B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Artificial Filaments (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a permselective hollow yarn membrane superior in mol.wt. fractionation properties within a medium and high mol.wt. region, in hollow yarn spinning of a cellulose derivative, by using a soln. with moisture content of a specific value as a core agent introduced into hollow yarn and setting a spinning draft to a specific value. SOLUTION: This hollow yarn membrane has permselectivity and is composed of a cellulose derivative and has an inner diameter of 150-300μm and a thickness of 20-60μm. In order to produce the hollow yarn membrane having an extremely thin dense layer formed on the inner surface thereof, it is necessary to use a core agent having coagulability to a dope emitted from a cap, that is, capable of desolvating a dope soln. at a time of spinning. By using an aq. soln. of an org. solvent as the core agent at a time of spinning, the dense layer can be formed on the inner surface of the hollow yarn membrane. Herein, the moisture content of the aq. soln. as the core agent must be 50wt.% or more, pref., 70wt.% or more. It is necessary to set a spining draft to 5 or less, desirably 3 or less.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、選択透過性中空糸
膜の製造方法に関するものである。詳しくは、セルロー
ス誘導体を乾湿式紡糸により環状スリットから吐出し、
中空糸膜を得るに際し、特定の芯剤と特定の紡糸ドラフ
トを採用することにより、分子量分画性の良好な中空糸
膜を安定に製造する方法を提供するものである。
TECHNICAL FIELD The present invention relates to a method for producing a selectively permeable hollow fiber membrane. Specifically, the cellulose derivative is discharged from the annular slit by dry-wet spinning,
An object of the present invention is to provide a method for stably producing a hollow fiber membrane having good molecular weight fractionation by employing a specific core agent and a specific spinning draft when obtaining a hollow fiber membrane.

【0002】更に詳細には、本発明により得られる中空
糸膜は優れた分離性能を呈する選択透過性を有するもの
であり、血液透析、血液濾過透析などの血液処理に適
し、特に中高分子量領域の有害物質を除去するのに適し
た選択透過性中空糸膜を提供するものである。
More specifically, the hollow fiber membrane obtained by the present invention has a selective permeability exhibiting excellent separation performance, and is suitable for blood treatment such as hemodialysis and hemofiltration dialysis. An object of the present invention is to provide a permselective hollow fiber membrane suitable for removing harmful substances.

【0003】[0003]

【従来技術】選択透過性中空糸膜は、逆浸透や血液透析
などにおいて従来より実用的に使用されてきている。特
に腎不全患者の血液を浄化するために、現在では中空糸
型血液透析器がよく使用されている。これは筐体の中に
透析膜、例えば中空糸の膜を多数本収納し、その中空内
部に患者の血液を流し、外部、即ち中空糸間隙部に透析
液を流して、中空糸膜壁を介して透析によって、血液中
の老廃物を除去し電解質濃度を是正するとともに、中空
糸内外に圧力差を与えて限外濾過によって血液中の余剰
水分を除去するものである。
2. Description of the Related Art Permselective hollow fiber membranes have been practically used in reverse osmosis and hemodialysis. In particular, hollow fiber hemodialyzers are often used at present for purifying blood of patients with renal failure. In this case, a large number of dialysis membranes, for example, hollow fiber membranes, are housed in a housing, blood of a patient is allowed to flow inside the hollow, and dialysate is allowed to flow outside, that is, a gap between the hollow fibers, and the hollow fiber membrane wall is formed. Through the dialysis, waste substances in the blood are removed to correct the electrolyte concentration, and a pressure difference is applied between the inside and outside of the hollow fiber to remove excess water in the blood by ultrafiltration.

【0004】更に、血液中から血漿のみを分離し、ある
いは、その血漿の中から特定成分を除去して自己免疫疾
患などを治療するために中空糸が使用されることもあ
る。
[0004] Further, hollow fibers are sometimes used to separate only plasma from blood or remove specific components from the plasma to treat autoimmune diseases and the like.

【0005】また、最近になってタンパク透過性血液透
析やタンパク透過性血液濾過透析に中空糸を用いること
によって治療効果が得られることが確認されるようにな
ってきている。
[0005] Recently, it has been confirmed that a therapeutic effect can be obtained by using a hollow fiber in protein permeable hemodialysis or protein permeable hemodialysis.

【0006】このように血液処理用の中空糸は目的に応
じて特定の物質を選択的に透過させなければならない。
その性質は中空糸の素材、ポロシティ(孔の大きさ、数
など)、膜厚などによって決定される。
[0006] As described above, the hollow fiber for blood treatment must selectively allow a specific substance to permeate according to the purpose.
Its properties are determined by the material, porosity (size, number, etc.) of the hollow fiber, film thickness, and the like.

【0007】ところで、近年透析患者の長期合併症と関
連し、透析アミロイドシスの原因物質として考えられる
β2-ミクログロブリン(β2-MG、分子量11、80
0)、掻痒感、高脂血症と関係すると考えられる副甲状
腺ホルモン(分子量約9、500)、貧血に関与する赤
芽球抑制因子(分子量約1、000)、関節痛、骨痛に
係わると考えられる分子量2〜4万の物質など、比較的
中高分子量領域の有害物質の除去の必要性が叫ばれてい
る。一方、人体に必須のアルブミン(分子量66、00
0)の損失は極力避けなければならない。即ち、分子量
4〜5万以下の物質透過性に優れ、一方分子量6万以上
の物質の透過阻止性のよい、分画分子量のシャープカッ
ト性の良好な選択透過性膜が望まれている。
By the way, β 2 -microglobulin (β 2 -MG, molecular weight 11, 80, which is recently associated with long-term complications of dialysis patients and is considered as a causative substance of dialysis amyloidosis.
0), parathyroid hormone (molecular weight of about 9,500) considered to be associated with pruritus and hyperlipidemia, erythroblast inhibitory factor (molecular weight of about 1,000) involved in anemia, joint pain, and bone pain The necessity of removing harmful substances in a relatively medium-high molecular weight region, such as substances having a molecular weight of 20,000 to 40,000, which are considered to be considered, is called for. On the other hand, albumin essential for the human body (molecular weight 66,00
The loss of 0) must be avoided as much as possible. That is, there is a demand for a permselective membrane which is excellent in permeability of substances having a molecular weight of 40,000 to 50,000 or less, has good blocking properties for substances having a molecular weight of 60,000 or more, and has good sharp cutoff of the molecular weight cutoff.

【0008】しかるに、従来、ポリスルホンなどの合成
高分子では、例えば特公平2−18695号公報や特公
平5−54373号公報に見られるように、比較的上記
要求を満たしたものが得られているが、セルロース誘導
体、特にトリアセテートでは、例えば特公昭58−24
165号公報に見られるように、中空糸を湿式紡糸する
ときの芯剤に流動パラフィン、高級アルコール、イソプ
ロピルミリステートなど、トリアセテート紡糸原液に対
して凝固性のないものを使用するために、紡糸原液にお
けるトリアセテートの濃度を高め、紡糸時の曵糸性を高
くせざるを得ない。また、紡糸原液をノズルから出糸
後、中空糸外面から凝固液で固化させるために、中空糸
外面に緻密構造の層が形成される。
However, conventionally, as a synthetic polymer such as polysulfone, a polymer which relatively satisfies the above requirements has been obtained as disclosed in Japanese Patent Publication No. 2-18695 and Japanese Patent Publication No. 5-54337. However, in the case of cellulose derivatives, particularly triacetate, for example, JP-B-58-24
As disclosed in JP-A-165-165, in order to use a non-coagulable triacetate spinning solution such as liquid paraffin, higher alcohol, or isopropyl myristate as a core agent for wet spinning a hollow fiber, In this case, the triacetate concentration must be increased to increase the spinnability during spinning. In addition, a layer having a dense structure is formed on the outer surface of the hollow fiber in order to solidify the spinning stock solution from the nozzle and then solidify the outer surface of the hollow fiber with the coagulating liquid.

【0009】これらの理由により、従来、セルロース誘
導体中空糸は、合成ポリマーの膜に比べて構造の緻密層
と多孔層の密度差が小さく、全体として均一層に近く、
物質の透過性能が十分とはいえなかった。そのために膜
の厚さを減少させ、透過性の向上を図ってきたが十分な
ものとはいえない。更に膜構造の緻密層と多孔層の密度
差が不明確なために、物質の分画特性においても改良の
余地のあるものである。
[0009] For these reasons, conventionally, the cellulose derivative hollow fiber has a smaller density difference between the dense layer and the porous layer of the structure than the synthetic polymer membrane, and is close to a uniform layer as a whole.
The permeability of the substance was not sufficient. For this purpose, the thickness of the film has been reduced to improve the transmittance, but this is not sufficient. Further, since the density difference between the dense layer and the porous layer having the membrane structure is unclear, there is room for improvement in the fractionation characteristics of the substance.

【0010】[0010]

【発明が解決しようとする課題】本発明は、このような
従来技術の問題点を解決することを目的とするものであ
り、セルロース誘導体のポリマーを使用して、従来の合
成ポリマーの構造に近い粗密構造を与え、高い分子量分
画特性を付与するものである。特に血液透析や血液濾過
透析において、β2-MGなどの中高分子量領域の有害物
質の除去とアルブミンなどの有用物質の流出阻止性を高
めることが可能な選択透過性中空糸膜の製造方法を提供
するものである。
SUMMARY OF THE INVENTION An object of the present invention is to solve such problems of the prior art, and to use a cellulose derivative polymer to approximate the structure of a conventional synthetic polymer. It provides a dense and dense structure and imparts high molecular weight fractionation characteristics. Particularly, in hemodialysis and hemofiltration dialysis, a method for producing a selectively permeable hollow fiber membrane capable of removing harmful substances in the medium-high molecular weight region such as β 2 -MG and improving the outflow prevention of useful substances such as albumin is provided. Is what you do.

【0011】[0011]

【課題を解決するための手段】本発明者は、かかる課題
を解決するために鋭意検討した結果、セルロース誘導体
の乾湿式法による中空糸紡糸において、中空糸内側に導
入する芯剤として水分含量が50%以上の溶液を使用
し、また、紡糸におけるドラフト、即ち口金におけるド
ープの吐出線速度に対する中空糸の引き取り速度の比を
5以下にすることにより、前述した中空糸内面に薄い緻
密層を有し、その外側が多孔質状の構造を有し、特に中
高分子量領域での分子量分画性の良好なセルロース誘導
体からなる中空糸膜を、紡糸中の糸切れなどのトラブル
なく安定に製造できることを見いだした。
Means for Solving the Problems The inventors of the present invention have made intensive studies to solve the above-mentioned problems, and as a result, in a hollow fiber spinning of a cellulose derivative by a dry-wet method, the water content as a core agent introduced into the inside of the hollow fiber is reduced. A thin dense layer is formed on the inner surface of the hollow fiber by using a solution of 50% or more and making the draft in spinning, that is, the ratio of the take-up speed of the hollow fiber to the discharge linear speed of the dope in the spinneret, 5 or less. In addition, a hollow fiber membrane having a porous structure on the outside and a cellulose derivative having a good molecular weight fractionation property in a medium-high molecular weight region can be produced stably without trouble such as thread breakage during spinning. I found it.

【0012】[0012]

【発明の実施の形態】以下、本発明について更に詳細に
説明する。即ち、本発明における中空糸膜は選択透過性
を有するものであり、その素材としてはセルロース誘導
体、特にアセチルセルロースであり、その中でも一般的
に使用されるものとしては、実質的にセルロースジアセ
テート、セルローストリアセテートからなる高分子であ
る。尚、実質的とは、このセルロース誘導体の特性を損
なわない範囲で他の高分子、添加物などを含有しても良
いことを意味する。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in more detail. That is, the hollow fiber membrane in the present invention is a material having selective permeability, the material of which is a cellulose derivative, particularly acetylcellulose, and among those generally used, substantially cellulose diacetate, It is a polymer composed of cellulose triacetate. Note that “substantially” means that other polymers, additives, and the like may be contained as long as the properties of the cellulose derivative are not impaired.

【0013】また本発明の中空糸膜の膜壁の構造に関し
ては、物質の分離透過特性と機械特性を機能分担させる
ような、極薄緻密層と、機械的に流体圧力に耐えられる
が物質の透過抵抗には殆どならない多孔層とを合わせ持
つような、従来合成高分子で実現されていた2層又は多
層構造が好ましい。特に、中空糸膜の内面を通して血液
を処理する場合には、少なくとも中空糸内面に緻密層が
あるのが望ましい。内面に多孔層があると、その部分に
血中蛋白質が付着したり、あるいは孔中に侵入したりし
て、物質透過の阻害になる懸念がある。
The structure of the membrane wall of the hollow fiber membrane of the present invention is characterized by an ultrathin dense layer which functions to separate and permeate the separation and permeation properties of the substance and the mechanical properties, and a material which can mechanically withstand the fluid pressure but is capable of withstanding the fluid pressure. A two-layer or multi-layer structure conventionally realized with a synthetic polymer, which has a porous layer that has almost no permeation resistance, is preferable. In particular, when blood is processed through the inner surface of the hollow fiber membrane, it is desirable that there is a dense layer at least on the inner surface of the hollow fiber. If there is a porous layer on the inner surface, there is a concern that blood proteins may adhere to that portion or penetrate into the pores, thereby impeding the permeation of substances.

【0014】この様な中空糸膜内面に極薄緻密層を有す
る膜を製造するには、紡糸に際し、口金から吐出される
ドープに対し凝固性を有する、即ちドープの溶液を脱溶
剤できる芯剤を使用する必要がある。
In order to produce such a membrane having an ultra-thin dense layer on the inner surface of the hollow fiber membrane, a core agent which has coagulability with respect to the dope discharged from the spinneret during spinning, that is, which can desolvate the solution of the dope. You need to use

【0015】セルロース誘導体の溶剤としては、一般に
N−メチルピロリドン、ジメチルホルムアミド、ジメチ
ルアセトアミド、ジメチルスルホキシドなどが使用され
るが、これらの有機溶剤に対して水は良好な相溶性を有
し、セルロース誘導体ドープに対して凝固性を示す。従
って、紡糸時の芯剤として水溶液を使用することにより
中空糸膜内面に緻密層を成形することができる。
As the solvent for the cellulose derivative, N-methylpyrrolidone, dimethylformamide, dimethylacetamide, dimethylsulfoxide and the like are generally used. Water has good compatibility with these organic solvents, and Shows coagulability with dope. Therefore, a dense layer can be formed on the inner surface of the hollow fiber membrane by using an aqueous solution as a core agent during spinning.

【0016】水溶液としては前記溶剤の水溶液が一般に
使用できるが、その他に膨潤剤、非溶剤その他の添加物
を含む場合もある。膨潤剤としてはホルムアミド、尿
素、リン酸トリエチル、グリオキサール、ブタノール、
イソプロパノール等があり、又非溶剤としてはエチレン
グリコール、トリエチレングリコール、ポリエチレング
リコール、グリセリン、プロピレングリコール、アルコ
ール類などがある。
As the aqueous solution, an aqueous solution of the above-mentioned solvent can be generally used, but may further contain a swelling agent, a non-solvent and other additives. Swelling agents include formamide, urea, triethyl phosphate, glyoxal, butanol,
Isopropanol and the like, and non-solvents include ethylene glycol, triethylene glycol, polyethylene glycol, glycerin, propylene glycol and alcohols.

【0017】この水溶液の水分含量が50%を下回る
と、中高分子量物質の分子量分画性能を付与する極薄緻
密層が形成されない。芯剤としての水溶液の水分含量は
50重量%以上であることが必要であり、好ましくは7
0重量%以上である。
If the water content of the aqueous solution is less than 50%, an ultra-thin dense layer for imparting the molecular weight fractionation performance of a medium-high molecular weight substance will not be formed. The water content of the aqueous solution as the core agent must be 50% by weight or more, and is preferably 7% by weight.
0% by weight or more.

【0018】一方、水溶液の水分含量が高くなると口金
から吐出されたドープの凝固が急激に進行するために曳
糸性が低下し、糸切れが発生しやすくなる。この為に紡
糸ドラフトとしては5以下にする必要がある。望ましく
は3以下である。
On the other hand, when the water content of the aqueous solution is high, the dope discharged from the spinneret rapidly solidifies, so that the spinnability is lowered and the yarn breaks easily. For this reason, the spinning draft needs to be 5 or less. It is desirably 3 or less.

【0019】本発明で得られる選択透過性中空糸膜の主
な用途である血液浄化の場合には、その中空糸の内径は
150〜300μmが一般的であり、この場合には口金
の環状スリットの外径は0.5mmφ以下にするのが口
金工作上実際的であり、工作精度上も望ましい。更に好
ましくは0.4mmφ以下である。
In the case of blood purification, which is the main use of the permselective hollow fiber membrane obtained in the present invention, the hollow fiber generally has an inner diameter of 150 to 300 μm. It is practical to make the outer diameter of 0.5 mmφ or less from the viewpoint of die working, and is also desirable in terms of working accuracy. More preferably, it is 0.4 mmφ or less.

【0020】本発明に係わる中空糸膜の膜厚は、一般に
物質の透過性からみれば薄いのが望ましいが、本発明に
かかる様な2層以上のものでは、多孔層を有するために
機械的強度の点より20μm以上が好ましい。一方60
μm以上では物質の透過性が低下してくる。
In general, the thickness of the hollow fiber membrane according to the present invention is desirably small in view of the permeability of a substance. It is preferably at least 20 μm from the viewpoint of strength. On the other hand 60
Above μm, the permeability of the substance decreases.

【0021】このように本発明の中空糸膜の製造方法
は、血液透析器や血液濾過透析に使用した場合に、β2-
MGなどの中高分子量の領域の有害物質の除去性能が高
く、人体に有益なアルブミンの損失量が少ないという選
択透過性に優れた中空糸膜を、糸切れなどのトラブルな
く安定して紡糸することの出来る製造方法である。
As described above, the method for producing a hollow fiber membrane of the present invention, when used in a hemodialyzer or hemofiltration dialysis, has a β 2-
Highly selective removal of harmful substances in the medium and high molecular weight areas such as MG and a small amount of albumin that is beneficial to the human body. It is a manufacturing method that can be performed.

【0022】かかる本発明の中空糸膜の製造方法は特に
限定されるものではないが、望ましくはセルロース誘導
体を有機溶剤に溶解した紡糸原液を、芯剤として水溶液
を用いて、チューブインオリフィス状ノズルより吐出さ
せ、気体中を通過後、水溶性凝固液中に通し固化させる
方式が採用される。
Although the method for producing the hollow fiber membrane of the present invention is not particularly limited, a tube-in-orifice nozzle is desirably prepared by using a spinning stock solution obtained by dissolving a cellulose derivative in an organic solvent and using an aqueous solution as a core agent. A method is adopted in which the liquid is discharged more, passes through a gas, and then passes through a water-soluble coagulating liquid and solidifies.

【0023】[0023]

【実施例】以下本発明について実施例を挙げて更に具体
的に説明するが、本発明は、これらの実施例によって何
ら限定されるものではない。
EXAMPLES The present invention will be described more specifically below with reference to examples, but the present invention is not limited to these examples.

【0024】[実施例1〜4、比較例1〜5]セルロー
ストリアセテート13部とトリエチレングリコール20
部を、ジメチルスルホキジド67部に均一に溶解したも
のを紡糸原液として、環状スリット型ノズルより、ジメ
チルスルホキシドの水溶液を芯剤として、空気中に吐出
させた後、凝固液の中に導いて固化させ、水洗、グリセ
リン付着処理後、巻き取った。かかる中空糸の内径は約
200μm、膜厚は約45μmであった。得られた中空
糸膜を乾燥後束状にして、円管状の容器に挿入充填し
て、両端をポリウレタンで接着固定し、有効面積が約
1.5m2 の血液透析器を作成し、in vitroで
のデキストラン10,000の総括物質移動係数
(K0 )及び牛血漿を用いたアルブミンの篩係数(S
C)を測定した。
Examples 1 to 4 and Comparative Examples 1 to 5 13 parts of cellulose triacetate and triethylene glycol 20
Part was dissolved uniformly in 67 parts of dimethyl sulfoxide as a spinning dope, and from an annular slit type nozzle, an aqueous solution of dimethyl sulfoxide was used as a core material and discharged into the air. After solidification, washing with water and glycerin adhesion treatment, it was wound up. The hollow fiber had an inner diameter of about 200 μm and a film thickness of about 45 μm. The obtained hollow fiber membranes are dried, bundled, inserted and filled in a cylindrical container, and both ends are adhered and fixed with polyurethane to prepare a hemodialyzer having an effective area of about 1.5 m 2. Mass transfer coefficient (K 0 ) of dextran 10,000 at room temperature and sieving coefficient of albumin using bovine plasma (S
C) was measured.

【0025】尚、かかるK0 の測定方法としては、円筒
状容器に約52%の充填率で中空糸束を充填して両端を
接着剤でシール固化した後切断して中空部を開口するこ
とにより1.5m2 の有効膜表面積の透析器を組み立て
たものを用いて、37℃において血液側すなわち中空部
側に0.1重量%のデキストラン10,000の水溶液
を200ml/分で流し、透析液側すなわち中空糸間隙
部側に水を500ml/分で流した場合の血液側の流出
液中の濃度を測定することによって、下記式によりK0
が得られる。サンプリング液中のデキストラン濃度は、
例えばアンスロン−硫酸法により測定する。
As a method of measuring K 0 , a hollow cylindrical fiber container is filled with a bundle of hollow fibers at a filling rate of about 52%, both ends are sealed with an adhesive, and then cut to open a hollow portion. Using a dialyzer having an effective membrane surface area of 1.5 m 2 according to the above, an aqueous solution of 0.1% by weight of dextran 10,000 at 200 ml / min was flowed at 37 ° C. to the blood side, that is, the hollow side at 200 ml / min. By measuring the concentration in the effluent on the blood side when water is flowed at 500 ml / min on the liquid side, that is, on the hollow fiber gap side, K 0 is calculated by the following equation.
Is obtained. Dextran concentration in the sampling solution is
For example, it is measured by the anthrone-sulfuric acid method.

【0026】[0026]

【数1】 (Equation 1)

【0027】QB :血液側の流量[ml/sec] QD :透析液側の流量[ml/sec] DA :デキストラン10,000のダイアリザンスで、
その測定法は日本透析医学会学術委員会in vitr
o評価ワーキンググループの評価法に基づく。 A :中空糸膜有効膜面積[cm2 ]:中空糸膜の湿潤
状態での内径基準の膜面積である。
[0027] Q B: blood-side flow rate [ml / sec] Q D: flow rate of the dialysate side [ml / sec] DA: in the dialysance of dextran 10,000,
The measurement method is in vitro by the Japanese Dialysis Medical Association Scientific Committee
o Based on the evaluation working group evaluation method. A: Effective membrane area of hollow fiber membrane [cm 2 ]: Membrane area based on the inner diameter of the hollow fiber membrane in a wet state.

【0028】また、アルブミンの篩係数(SC)の測定
方法は、日本透析医学会学術委員会の血液浄化器の牛血
漿のin vitro評価プロトコールと機能分類
(案)('94.11.12 )による。アルブミン濃度の測定
は、A/G B−テストワコー(和光純薬(株))によ
り行った。その結果を表1に示す。
The method for measuring the sieving coefficient (SC) of albumin is based on the in vitro evaluation protocol and functional classification (draft) ('94 .11.12) of bovine plasma in blood purifiers by the Scientific Committee of the Japanese Society for Dialysis Therapy. The measurement of albumin concentration was performed by A / GB-Test Wako (Wako Pure Chemical Industries, Ltd.). Table 1 shows the results.

【0029】[0029]

【表1】 [Table 1]

【0030】表1は、紡糸条件と紡糸調子、及び、in
vitro性能を示したものである。本発明の中空糸
の製造方法は、デキストラン10,000のK0 が大き
く、アルブミンの篩係数が小さく、分画性の良好な選択
透過性中空糸膜を紡糸調子よく安定して製造するものに
なっている。
Table 1 shows spinning conditions, spinning conditions, and in
It shows the in vitro performance. The method for producing a hollow fiber of the present invention is a method for stably producing a selectively permeable hollow fiber membrane having a large K 0 of 10,000 dextran, a small sieving coefficient of albumin, and a good fractionation property. Has become.

【0031】[0031]

【発明の効果】本発明のセルロース誘導体の選択透過性
中空糸膜の製造方法により、糸切れが少なく安定的にセ
ルロース誘導体の中空糸膜を紡糸することができ、中高
分子量領域の透過性能が高く、アルブミンの透過が少な
いという優れた分画性を持った選択透過性中空糸膜を提
供できる。
According to the method for producing a cellulose derivative selectively permeable hollow fiber membrane of the present invention, a cellulose derivative hollow fiber membrane can be stably spun with less thread breakage, and has a high permeability in a medium-high molecular weight region. And a selectively permeable hollow fiber membrane having an excellent fractionation property of low permeation of albumin.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 実質的にセルロース誘導体からなる重合
体を有機溶剤に溶解し、次いでこの溶液を環状スリット
から線状押出すると同時に、水分含量が50重量%以上
の溶液を前記押出された線状体の内側に導入し、紡糸ド
ラフトを5以下で引き取ることを特徴とする、内径15
0〜300μm、膜厚20〜60μmの実質的にセルロ
ースエステルからなる選択透過性中空糸膜の製造方法。
1. A polymer substantially consisting of a cellulose derivative is dissolved in an organic solvent, and then this solution is linearly extruded from an annular slit, and simultaneously a solution having a water content of 50% by weight or more is extruded. Characterized in that it is introduced inside the body, and the spinning draft is taken off at less than 5;
A method for producing a permselective hollow fiber membrane substantially consisting of cellulose ester having a thickness of 0 to 300 µm and a thickness of 20 to 60 µm.
【請求項2】 該環状スリットの外径が0.5mmφ以
下である請求項1記載の選択透過性中空糸膜。
2. The permselective hollow fiber membrane according to claim 1, wherein the outer diameter of said annular slit is 0.5 mmφ or less.
【請求項3】 該セルロース誘導体がセルローストリア
セテートである請求項1記載の選択透過性中空糸膜の製
造方法。
3. The method for producing a permselective hollow fiber membrane according to claim 1, wherein said cellulose derivative is cellulose triacetate.
【請求項4】 該有機溶剤がN−メチルピロリドン、ジ
メチルホルムアミド、ジメチルアセトアミド、ジメチル
スルホキシドから選ばれた1種類の溶剤又は2種類以上
の混合物である請求項1記載の選択透過性中空糸膜の製
造方法。
4. The selectively permeable hollow fiber membrane according to claim 1, wherein the organic solvent is one kind of solvent selected from N-methylpyrrolidone, dimethylformamide, dimethylacetamide, and dimethylsulfoxide or a mixture of two or more kinds. Production method.
【請求項5】 該選択透過性中空糸膜が少なくとも内面
に緻密層を有する請求項1記載の選択透過性中空糸膜の
製造方法。
5. The method for producing a selectively permeable hollow fiber membrane according to claim 1, wherein said selectively permeable hollow fiber membrane has a dense layer at least on an inner surface.
JP32528196A 1996-04-19 1996-12-05 Method for producing selectively permeable hollow fiber membrane Expired - Lifetime JP3236233B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP32528196A JP3236233B2 (en) 1996-12-05 1996-12-05 Method for producing selectively permeable hollow fiber membrane
CA002202969A CA2202969C (en) 1996-04-19 1997-04-17 Selectively permeable hollow fiber membrane and process for producing same
EP97302660A EP0801973A1 (en) 1996-04-19 1997-04-18 Selectively permeable hollow fiber membrane and process for producing same
US08/837,475 US6013182A (en) 1996-04-19 1997-04-18 Selectively permeable hollow fiber membrane and process for producing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32528196A JP3236233B2 (en) 1996-12-05 1996-12-05 Method for producing selectively permeable hollow fiber membrane

Publications (2)

Publication Number Publication Date
JPH10165775A true JPH10165775A (en) 1998-06-23
JP3236233B2 JP3236233B2 (en) 2001-12-10

Family

ID=18175068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32528196A Expired - Lifetime JP3236233B2 (en) 1996-04-19 1996-12-05 Method for producing selectively permeable hollow fiber membrane

Country Status (1)

Country Link
JP (1) JP3236233B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008178814A (en) * 2007-01-25 2008-08-07 Toyobo Co Ltd Cellulose acetate-based non-symmetrical hollow fiber membrane

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008178814A (en) * 2007-01-25 2008-08-07 Toyobo Co Ltd Cellulose acetate-based non-symmetrical hollow fiber membrane

Also Published As

Publication number Publication date
JP3236233B2 (en) 2001-12-10

Similar Documents

Publication Publication Date Title
US4874522A (en) Polysulfone hollow fiber membrane and process for making the same
US6103117A (en) Polysulfone hollow fiber semipermeable membrane
US6013182A (en) Selectively permeable hollow fiber membrane and process for producing same
EP0012630B1 (en) Process for producing a cellulose acetate-type permselective membrane, permselective membrane thus produced, and use of such membrane in artificial kidney
JP3714686B2 (en) Polysulfone-based hollow fiber membrane and method for producing the same
JP5212837B2 (en) Permselective hollow fiber membrane
JP3253861B2 (en) Permselective hollow fiber membrane
JP3295321B2 (en) Permselective hollow fiber membrane
JPH053335B2 (en)
JP3212313B2 (en) Hollow fiber blood purification membrane and method for producing the same
JPH10216489A (en) Cellulose hollow fiber membrane and its production
JP3236233B2 (en) Method for producing selectively permeable hollow fiber membrane
JPH10263375A (en) Selective permeable hollow fiber membrane
JPH09308685A (en) Hollow fiber membrane for blood purification and blood purifying device
JP3424807B2 (en) Hollow fiber membrane
JP2000107577A (en) Production of permselective hollow fiber membranes
JP3253867B2 (en) Permselective hollow fiber membrane
JP3205268B2 (en) Method for producing selectively permeable hollow fiber membrane
JP3253885B2 (en) Permselective hollow fiber membrane
JP3205267B2 (en) Method for producing selectively permeable hollow fiber membrane
JP3295314B2 (en) Permselective hollow fiber membrane
JP3316145B2 (en) Permselective hollow fiber membrane and method for producing the same
JP4386607B2 (en) Polysulfone blood purification membrane production method and polysulfone blood purification membrane
JP2710711B2 (en) Cellulose diacetate hollow fiber
JP3345260B2 (en) Permselective hollow fiber membrane